Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Perez-Lanzon

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Oncoimmunology|March 26, 2019
Failure of immunosurveillance accelerates agingMaria Perez-Lanzon, Laurence Zitvogel, Guido Kroemer
International Review of Cell and Molecular Biology|March 20, 2018
Organoids for Modeling Genetic DiseasesMaria Perez-Lanzon, Guido Kroemer, Maria Chiara Maiuri
Oncoimmunology|October 29, 2021
Crizotinib and ceritinib trigger immunogenic cell death via on-target effectsAdriana Petrazzuolo, Maria Perez-Lanzon, Peng Liu, et al.
Cell Death & Disease|July 17, 2021
Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effectsAdriana Petrazzuolo, Maria Perez-Lanzon, Isabelle Martins, et al.
Oncoimmunology|October 25, 2019
Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunityWei Xie, Sabrina Forveille, Kristina Iribarren, et al.
Methods in Cell Biology|September 10, 2025
Orthotopic model of tongue cancer for the study of head and neck squamous cell carcinoma in miceSarah Adriana Scuderi, Fatima Domenica Elisa De Palma, Deborah Mannino, et al.
Journal for Immunotherapy of Cancer|June 21, 2023
New hormone receptor-positive breast cancer mouse cell line mimicking the immune microenvironment of anti-PD-1 resistant mammary carcinomaMaria Perez-Lanzon, Vincent Carbonnier, Pierre Cordier, et al.
Cell Death and Differentiation|January 20, 2025
Epigenetic regulation of HOXA2 expression affects tumor progression and predicts breast cancer patient survivalFatima Domenica Elisa De Palma, Jonathan G Pol, Vincent Carbonnier, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Oncoimmunology|March 26, 2019
Failure of immunosurveillance accelerates agingMaria Perez-Lanzon, Laurence Zitvogel, Guido Kroemer
International Review of Cell and Molecular Biology|March 20, 2018
Organoids for Modeling Genetic DiseasesMaria Perez-Lanzon, Guido Kroemer, Maria Chiara Maiuri
Oncoimmunology|October 29, 2021
Crizotinib and ceritinib trigger immunogenic cell death via on-target effectsAdriana Petrazzuolo, Maria Perez-Lanzon, Peng Liu, et al.
Cell Death & Disease|July 17, 2021
Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effectsAdriana Petrazzuolo, Maria Perez-Lanzon, Isabelle Martins, et al.
Oncoimmunology|October 25, 2019
Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunityWei Xie, Sabrina Forveille, Kristina Iribarren, et al.
Methods in Cell Biology|September 10, 2025
Orthotopic model of tongue cancer for the study of head and neck squamous cell carcinoma in miceSarah Adriana Scuderi, Fatima Domenica Elisa De Palma, Deborah Mannino, et al.
Journal for Immunotherapy of Cancer|June 21, 2023
New hormone receptor-positive breast cancer mouse cell line mimicking the immune microenvironment of anti-PD-1 resistant mammary carcinomaMaria Perez-Lanzon, Vincent Carbonnier, Pierre Cordier, et al.
Cell Death and Differentiation|January 20, 2025
Epigenetic regulation of HOXA2 expression affects tumor progression and predicts breast cancer patient survivalFatima Domenica Elisa De Palma, Jonathan G Pol, Vincent Carbonnier, et al.
Pageof 1